Consequently, targeting one carbon metabolism that contributes via NADPH production to the cellular antioxidants response [e.g., by inhibiting methylenetetrahydrofolate dehydrogenase (MTHFD1)] decreases the survival of cancer cells in the circulation and subsequently metastasis formation in distant organs (20). Here, MTHFD1 is linked to cancer.